Aileron Therapeutics, Inc.ALRNNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-65.11M
↓ 141% below average
Average (9y)
$-26.97M
Historical baseline
Range
High:$-12.57M
Low:$-65.11M
CAGR
+20.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.11M | -317.0% |
| 2023 | $-15.61M | +43.2% |
| 2022 | $-27.48M | -3.8% |
| 2021 | $-26.48M | -30.3% |
| 2020 | $-20.33M | +31.8% |
| 2019 | $-29.80M | +4.9% |
| 2018 | $-31.33M | -36.2% |
| 2017 | $-23.01M | -28.3% |
| 2016 | $-17.94M | -42.7% |
| 2015 | $-12.57M | - |